U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
157621157621A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)CompletedHas ResultsHypercholesterolemiaDrug: simvastatin (+) ezetimibe|Drug: Comparator: atorvastatinhttps://ClinicalTrials.gov/show/NCT00496730
157622157622Aorta Calcium ScoringCompletedNo Results AvailableCardiovascular DiseasesDevice: Helicoidal fast scannhttps://ClinicalTrials.gov/show/NCT00496717
157623157623Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanRecruitingNo Results AvailableColorectal CancerDrug: capecitabine|Drug: gemcitabine hydrochloride|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00496704
157624157624HIV Prevention for Youth With Severe Mental IllnessCompletedNo Results AvailableHIV InfectionsBehavioral: Family-based HIV prevention programhttps://ClinicalTrials.gov/show/NCT00496691
157625157625Trial of Patient Navigation-ActivationCompletedNo Results AvailableBreast Cancer|Colorectal CancerBehavioral: Navigation|Behavioral: Standard of Carehttps://ClinicalTrials.gov/show/NCT00496678
157626157626ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerCompletedNo Results AvailableMetastatic Breast CancerDrug: Vandetanib|Drug: Cyclophosphamide|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00496665
157627157627DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCCActive, not recruitingNo Results AvailableCancer of the Head and NeckRadiation: Radiotherapy|Drug: Zalutumumabhttps://ClinicalTrials.gov/show/NCT00496652
157628157628Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term OutcomesRecruitingNo Results AvailableHyperplasia|StenosisProcedure: angioplasty|Procedure: stent placementhttps://ClinicalTrials.gov/show/NCT00496639
157629157629An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)CompletedHas ResultsPapillomavirus InfectionsBiological: Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)|Biological: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00496626
157630157630Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer SurvivorsActive, not recruitingNo Results AvailableBreast Cancer|Long-Term SurvivorsBehavioral: Mini-Mental State Exam and Blood draw|Behavioral: Mini-Mental State Exam and Blood Draw|Behavioral: Mini-Mental State Exam and Blood Drawhttps://ClinicalTrials.gov/show/NCT00496613
157631157631Phase I Study of Patupilone and RAD001CompletedNo Results AvailableRefractory MalignancyDrug: Patupilone|Drug: RAD001https://ClinicalTrials.gov/show/NCT00496600
157632157632Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaActive, not recruitingNo Results AvailableRenal Cell Carcinoma|Kidney CancerDrug: Capecitabine|Drug: Gemcitabine|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00496587
157633157633Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial AsthmaRecruitingNo Results AvailableAsthmaBiological: Novo Helisen Depot, Phostalhttps://ClinicalTrials.gov/show/NCT00496574
157634157634Effect of Specific Immunotherapy to Dust Mites in Children With AsthmaRecruitingNo Results AvailableAsthmaBiological: subcutaneous immunotherapy (House Dust Mites)|Other: placebo of subcutaneous immunotherapy (House Dust Mites)https://ClinicalTrials.gov/show/NCT00496561
157635157635Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease ActivityActive, not recruitingNo Results AvailableCrohn's DiseaseProcedure: Fecal calprotectin|Procedure: Urinary PGE-M Levelhttps://ClinicalTrials.gov/show/NCT00496548
157636157636A Study of TNFeradeâ„¢ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck CancerCompletedNo Results AvailableHead and Neck Cancer|Head and Neck NeoplasmsDrug: TNFerade biologichttps://ClinicalTrials.gov/show/NCT00496535
157637157637Proton Beam Therapy for ChondrosarcomaActive, not recruitingNo Results AvailableChondrosarcomaProcedure: Proton Beam Therapyhttps://ClinicalTrials.gov/show/NCT00496522
157638157638Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: ZD6474 (Zactima) 100mg|Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR)|Procedure: Biomarker Draws|Drug: ZD6474 (Zactima) 300mghttps://ClinicalTrials.gov/show/NCT00496509
157639157639Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant PatientsCompletedHas ResultsRenal FailureDrug: LCP Tacro (tacrolimus)|Drug: Prografhttps://ClinicalTrials.gov/show/NCT00496483
157640157640Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.CompletedHas ResultsChronic Obstructive Pulmonary Disease, COPDDrug: Symbicort (budesonide/formoterol turbuhaler 320/9ug)|Drug: Spiriva (tiotropium bromide 18ug)https://ClinicalTrials.gov/show/NCT00496470
157641157641Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic NeuropathyCompletedNo Results AvailableDiabetic NeuropathyDrug: Experimental|Drug: Placebo comparatorhttps://ClinicalTrials.gov/show/NCT00496457
157642157642Azacytidine and Valproic Acid in Patients With Advanced CancersCompletedNo Results AvailableAdvanced CancersDrug: Azacitidine|Drug: Valproic Acidhttps://ClinicalTrials.gov/show/NCT00496444
157643157643phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma PatientsTerminatedNo Results AvailableHodgkin's LymphomaDrug: histone deacetylase inhibitor (ITF2357)https://ClinicalTrials.gov/show/NCT00496431
157644157644Peristomal Mesh for Prophylaxis of Parastomal HerniaCompletedNo Results AvailableHerniaDevice: Mesh in permanent colostomyhttps://ClinicalTrials.gov/show/NCT00496418
157645157645Unilateral Bevacizumab for Bilateral Diabetic Macular EdemaCompletedNo Results AvailableDiabetic Macular Edema|Diabetic RetinopathyDrug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00496405
157646157646Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)CompletedNo Results AvailablePainDrug: Nasal fentanylhttps://ClinicalTrials.gov/show/NCT00496392
157647157647ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesTerminatedHas ResultsBreast Cancer|CNS DiseaseDrug: ZK219477https://ClinicalTrials.gov/show/NCT00496379
157648157648Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Metastatic Breast Cancer|Advanced Breast Cancer|HER2/Neu-positive Breast CancerDrug: Capecitabine|Drug: Lapatinibhttps://ClinicalTrials.gov/show/NCT00496366
157649157649MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)CompletedNo Results AvailableNeoplasmDrug: MK2461https://ClinicalTrials.gov/show/NCT00496353
157650157650Phase II Trial of Pentostatin and Targeted BusulfanCompletedHas ResultsHematologic MalignanciesDrug: Pentostatin|Drug: Busulfan|Drug: Rituximab|Procedure: Allogeneic Hematopoietic Cell Transplanthttps://ClinicalTrials.gov/show/NCT00496340

* Görseller ve İçerik tekif hakkına sahip olabilir